BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zamani M, Rahbar A, Shokri-Shirvani J. Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint. World J Gastroenterol 2017; 23(37): 6920-6922 [PMID: 29085236 DOI: 10.3748/wjg.v23.i37.6920]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6920.htm
Number Citing Articles
1
Menizibeya Osain Welcome. Gastrointestinal Physiology2018; : 991 doi: 10.1007/978-3-319-91056-7_14
2
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza, Elvira Garza-González. Helicobacter pyloridrug resistance: therapy changes and challengesExpert Review of Gastroenterology & Hepatology 2018; 12(8): 819 doi: 10.1080/17474124.2018.1496017
3
Chao-ran Ji, Jing Liu, Yue-yue Li, Chuan-guo Guo, Jun-yan Qu, Yan Zhang, Xiuli Zuo. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysisBMJ Open 2020; 10(10): e037375 doi: 10.1136/bmjopen-2020-037375
4
Dong-Min Yi, Tao-Tao Yang, Shuai-Heng Chao, Ya-Xin Li, Ying-Lei Zhou, Hai-Hui Zhang, Ling Lan, Yu-Wei Zhang, Xue-Mei Wang, Yan-Rui Zhang, Jian Li, Song-Ze Ding. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label studyMedicine 2019; 98(6): e14408 doi: 10.1097/MD.0000000000014408
5
Christina Kannigadu, David. D. N'Da. Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective DrugsCurrent Pharmaceutical Design 2020; 26(36): 4658 doi: 10.2174/1381612826666200331091853
6
Catrina Olivera, Vuong Van Hung Le, Catherine Davenport, Jasna Rakonjac. In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against Gram-negative pathogens Journal of Medical Microbiology 2021; 70(3) doi: 10.1099/jmm.0.001304
7
Jing Liu, Chao-Ran Ji, Yue-Yue Li, Chen Qiao, Jun-Nan Hu, Meng Wan, Min-Juan Lin, Bo-Shen Lin, Juan Wang, Jing Zha, Li-Xiang Li, Xiu-Li Zuo. Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot StudyClinical and Translational Gastroenterology 2021; 12(8): e00391 doi: 10.14309/ctg.0000000000000391
8
Farnaz Rasi-Bonab, Abolfazl Jafari-Sales, Mohammad Amin Shaverdi, Tahereh Navidifar, Morteza Saki, Atosa Ghorbani, Abimbola Olumide Adekanmbi, Behboud Jafari, Sara Naebi. Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, IranBMC Research Notes 2021; 14(1) doi: 10.1186/s13104-021-05633-5